“It was first understood as our main defense against opioid overdose,” Nguyen said. “The issue is that for some time, the FDA had not granted the approval of over-the-counter, non-prescription use of Naloxone because I think the standards for treating opioid overdoses were still being developed.”
Trending
- Baylor womens basketball dominates the paint in 100-66 win over East Texas A&M
- No. 23 Baylor volleyball battles back to reverse sweep Colorado
- No. 7 Texas holds off Baylor’s upset bid in 75-72 thriller
- No. 3 seed Baylor soccer’s late push falls short as No. 1 seed BYU wins Big 12 title
- No. 10 BYU downs Baylor 28-7 in disastrous weekend for the Bears
- Students race beds, taste chili at annual campus philanthropy event
- Baylor vs. No. 10 BYU moved to 6 p.m.
- FAA lifts ground stop, Baylor to leave Saturday morning for BYU game

